Business Wire·Aug 27, 2026, 1:00 AM ET

Materialise Reports Second Quarter and Half-Year 2026 Results

MTLS

Materialise NV reported total revenue of 70,073 kEUR for Q2 2026, an 8.1% increase from 64,831 kEUR in Q2 2025.
Adjusted EBITDA for Q2 2026 rose 15.7% to 9,593 kEUR, while Adjusted EBIT increased 26.9% to 3,880 kEUR.
Net profit for the second quarter of 2026 reached 3,331 kEUR (0.06 EUR per diluted share), compared to 199 kEUR in the prior year period.
The Materialise Medical segment drove growth with revenue increasing 12.2% to 36,873 kEUR in Q2 2026.
Revenue for the Materialise Software segment decreased 2.7% to 9,601 kEUR in Q2 2026, while the Manufacturing segment grew 6.7% to 23,597 kEUR.
For the first half of 2026, total revenue increased 3.9% to 136,349 kEUR, with Adjusted EBITDA rising 22.2% to 17,642 kEUR.
Net profit for the first half of 2026 was 5,152 kEUR (0.09 EUR per diluted share), reversing a net loss of (337) kEUR recorded in the same period in 2025.
The company maintained a net cash position of 74,214 kEUR at the end of Q2 2026, with 5,212 kEUR invested in share buybacks during the first half of the year.
Materialise completed the divestitures of its RapidFit and Eyewear business lines during the quarter.
The company reaffirmed its full-year 2026 revenue guidance of 273,000 to 283,000 kEUR.
Adjusted EBIT guidance for full-year 2026 was increased to a range of 12,000 to 14,000 kEUR, up from the previous range of 10,000 to 12,000 kEUR.
CEO Brigitte de Vet-Veithen highlighted strong execution in aerospace & defense markets and the launch of new CO-AM software offerings.
Free cash flow after operating and investing activities for the first half of 2026 amounted to 11,368 kEUR.
Gross profit as a percentage of revenue improved to 57.0% for the first half of 2026, up from 56.8% in 2025.
Research and development expenses increased by 7.4% to 24,203 kEUR for the first half of 2026.
A conference call to discuss these results is scheduled for August 27, 2026, at 8:30 a.m. ET.